第一作者:
Mohamed,Abou-El-Enein
第一单位:
Division of Medical Oncology, Department of Medicine and Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
作者:
Mohamed,Abou-El-Enein [1]
;
Aris,Angelis [2]
;
Frederick R,Appelbaum [3]
;
Nancy C,Andrews [4]
;
Susan E,Bates [5]
;
Arlene S,Bierman [6]
;
Malcolm K,Brenner [7]
;
Marina,Cavazzana [8]
;
Michael A,Caligiuri [9]
;
Hans,Clevers [10]
;
Emer,Cooke [11]
;
George Q,Daley [12]
;
Victor J,Dzau [13]
;
Lee M,Ellis [14]
;
Harvey V,Fineberg [15]
;
Lawrence S B,Goldstein [16]
;
Stephen,Gottschalk [17]
;
Margaret A,Hamburg [18]
;
Donald E,Ingber [19]
;
Donald B,Kohn [20]
;
Adrian R,Krainer [21]
;
Marcela V,Maus [22]
;
Peter,Marks [23]
;
Christine L,Mummery [24]
;
Roderic I,Pettigrew [25]
;
Joni L,Rutter [26]
;
Sarah A,Teichmann [17]
;
Andre,Terzic [18]
;
Fyodor D,Urnov [27]
;
David A,Williams [28]
;
Jedd D,Wolchok [29]
;
Mark,Lawler [30]
;
Cameron J,Turtle [31]
;
Gerhard,Bauer [18]
;
John P A,Ioannidis [32]
作者单位:
Division of Medical Oncology, Department of Medicine and Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
[1]
Joint USC/CHLA Cell Therapy Program, University of Southern California and Children's Hospital Los Angeles, Los Angeles, CA, USA.
[2]
Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
[3]
Department of Health Policy and LSE Health, London School of Economics and Political Science, London, UK.
[4]
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[5]
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
[6]
Department of Pharmacology and Cancer Biology and Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
[7]
Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, USA.
[8]
Center for Evidence and Practice Improvement, Agency for Healthcare Research and Quality, Rockville, MD, USA.
[9]
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
[10]
Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hopitaux de Paris, Paris, France.
[11]
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Quest, INSERM, Paris, France.
[12]
Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA, USA.
[13]
Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, the Netherlands.
[14]
University Medical Center Utrecht, Utrecht, the Netherlands.
[15]
European Medicines Agency, Amsterdam, the Netherlands.
[16]
Boston Children's Hospital, Boston, MA, USA.
[17]
Harvard Medical School, Boston, MA, USA.
[18]
US National Academy of Medicine, Washington, DC, USA.
[19]
Department of Surgical Oncology and Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[20]
Gordon and Betty Moore Foundation, Palo Alto, CA, USA.
[21]
Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
[22]
Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
[23]
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
[24]
American Association for the Advancement of Science (AAAS), Washington, DC, USA.
[25]
National Academy of Medicine, Washington, DC, USA.
[26]
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
[27]
Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA, USA.
[28]
Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
[29]
The Eli & Edith Broad Center of Regenerative Medicine & Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, USA.
[30]
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
[31]
Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
[32]
Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
[33]
Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, the Netherlands.
[34]
ENMED, Colleges of Medicine and Engineering, Texas A&M University, Houston, TX, USA.
[35]
National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
[36]
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
[37]
Theory of Condensed Matter, Cavendish Laboratory, University of Cambridge, JJ Thomson Ave, Cambridge, UK.
[38]
Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA.
[39]
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
[40]
Innovative Genomics Institute, University of California, Berkeley, CA, USA.
[41]
Division of Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
[42]
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[43]
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
[44]
Patrick G Johnston Centre for Cancer Research, Faculty of Medicine, Health and Life Sciences, Queen's University Belfast, Belfast, UK.
[45]
Institute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA.
[46]
Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA, USA.
[47]
Department of Epidemiology and Population Health and Department of Biomedical Data Sciences, Stanford University, Stanford, CA, USA.
[48]
DOI
10.1016/j.omtm.2021.06.012
PMID
34377737
发布时间
2024-04-04
- 浏览0
Molecular therapy. Methods & clinical development
2021年22卷
11-14页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文